Kolon TissueGene코오롱티슈진
950160 · KOSDAQ · ₩950160 · 코오롱티슈진
₩14,600▼ ₩160 (1.08%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩3.6M | ₩3.7M | ₩2.8M | ₩7.3M | ₩3.5M |
| Cost of sales | ₩3.1M | ₩3.3M | ₩2.5M | ₩1.4M | ₩3.1M |
| Gross profit | ₩481,814 | ₩435,847 | ₩316,534 | ₩6M | ₩382,974 |
| Operating income | −₩16M | −₩16M | −₩16M | −₩13M | −₩41M |
| Net income | −₩135M | −₩25M | −₩13M | −₩8.6M | −₩41M |
| Net income to shareholders | −₩135M | −₩25M | −₩13M | −₩8.6M | −₩41M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩295M | ₩151M | ₩105M | ₩87M | ₩52M |
| Current assets | ₩60M | ₩5M | ₩25M | ₩50M | ₩37M |
| Cash and equivalents | ₩47M | ₩546,173 | ₩21M | ₩33M | ₩33M |
| Total liabilities | ₩251M | ₩52M | ₩15M | ₩15M | ₩19M |
| Current liabilities | ₩248M | ₩48M | ₩11M | ₩9.2M | ₩14M |
| Borrowings | ₩52M | ₩7.4M | — | ₩395,424 | ₩0 |
| Total equity | ₩45M | ₩99M | ₩89M | ₩72M | ₩33M |
| Shareholders' equity | ₩45M | ₩99M | ₩89M | ₩72M | ₩33M |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩17M | −₩15M | −₩18M | −₩21M | −₩35M |
| Capital spending | ₩841,069 | ₩94,767 | ₩199,615 | ₩53,038 | ₩478,876 |
| Free cash flow | −₩18M | −₩15M | −₩19M | −₩21M | −₩35M |
Consolidated where available. Amounts in won.
Also known as: Kolon TissueGene / 코오롱티슈진 / 950160 / KRX:950160
Source: KRX statistical information